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Abstract
Background: There is strong evidence that left atrial (LA) size is a prognostic marker in a variety of heart diseases.
Recently, real-time three-dimensional echocardiography (RT3DE) has been reported as a useful tool for studying the
phasic changes of the left atrial volumes. The aim of this study was to investigate the performance of the left
atrium in beta-thalassemic patients with preserved left ventricular ejection fraction (EF) and no iron overload, using
RT3DE.
Methods: Twenty-eight asymptomatic b-thalassemic patients (32.2 ± 4.3 years old, 17 men) who were on iron
chelating therapy, as well as 20 age- and sex-matched healthy controls underwent transthoracic RT3DE. The patient
group had normal echocardiographic systolic and diastolic indices, while there was no myocardial iron disposition
according to MRI. Apical full volume data sets were obtained and LA volumes were measured at 3 time points of
the cardiac cycle: (1) maximum volume (LAmax) at end-systole, just before mitral valve opening; (2) minimum
volume (LAmin) at end-diastole, just before mitral valve closure; and (3) volume before atrial active contraction
(LApreA) obtained from the last frame before mitral valve reopening or at time of the P wave on the surface
electrocardiogram. From the derived values, left atrial active and passive emptying volumes, as well as the
respective emptying fractions were calculated.
Results: Left ventricular EF (59.2 ± 2.5% patients vs. 60.1 ± 2.1% controls), E/A, E/E’ were similar between the two
groups. Differences in the LAmax, LAmin and LApreA between b-thalassemic patients and controls were non-
significant, LAmax:(35.5 ± 13.4 vs 31.8 ± 9.8)cm
3, LAmin:(16.0 ± 6.0 vs. 13.5 ±4.2)cm
3, and LApreA:(25.4 ± 9.8 vs. 24.3
± 7.2)cm
3. However, left atrial active emptying fraction was reduced in the patient group as compared to the
healthy population (34.3 ± 16.4% vs. 43.2 ± 11.4%, p < 0.05).
Conclusion: RT3DE may be a novel technique for the evaluation of LA function in asymptomatic patients with b-
Thalassemia Major. Among three-dimensional volumes and indices, left atrial active emptying fraction may be an
early index of LA dysfunction in the specific patient population.
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Cardiac involvement represents an important complica-
tion of b-thalassemia major, and results in increased
mortality and morbidity rates. Disease mechanisms
implicate iron infiltration of the heart structures due to
frequent blood transfusions. Transfusion-dependent
patients receive 20 times the normal intake of iron,
which leads to iron accumulation and damage in the
liver, heart, and endocrine organs [1]. Although iron
chelating therapy has markedly improved outcomes, car-
diac failure remains an important cause of death in tha-
lassemic patients [2]. Therefore, early recognition of
myocardial dysfunction is imperative, given the fact that
majority of this patient group have preserved ejection
fraction until late in disease process.
On the other hand, left atrial (LA) enlargement plays a
pivotal role in the prognosis and management of various
cardiovascular diseases, including coronary artery dis-
ease and heart failure [3,4]. Recently real-time three-
dimensional echocardiography (RT3DE) has been inte-
grated into clinical practice, providing unique data on
phasic changes of LA volume during the cardiac cycle
[5]. Furthermore, it has been validated against cardiac
magnetic resonance (CMR) and has been proven as a
reliable and robust methodf o rt h ee v a l u a t i o no fL A
volume; being more accurate than conventional 2D
echocardiography [6].
The aim of the current study is to investigate the per-
formance of the left atrium in b-thalassemic patients
with preserved left ventricular ejection fraction (EF) and
no myocardial iron overload employing RT3DE.
Methods
Study population
Twenty-eight consecutive asymptomatic patients (32.2 ±
4.3 yrs old, 17 men) with b-Thalassemia major were ret-
rospectively studied, compared to twenty healthy age,
sex- and BMI- matched controls. Thalassemic patients
were on intense chelating therapy with deferipone (p.os)
and desferioxamine (i.v/s.c). All patients were on sinus
rhythm. Exclusion criteria included a medical history of
smoking, arterial hypertension, diabetes mellitus, as well
as the presence of heart failure and pulmonary hyperten-
sion symptoms (NYHA> Stage I). Structural and valvular
heart diseases were also within the exclusion criteria.
Additionally, patients with CMR-detected myocardial
iron overload during the previous six-month scan were
excluded from the study. A critical iron loading was
defined as a T2* value less than the threshold of 20 ms
(less than the lower limit value of the 95% confidence
interval of the normal T2* value as described by Ander-
son et al. [7]), and values equal to or greater than this
limit were considered to be uncritical. On the other
hand, the control group was consisted of individuals with
unremarkable clinical history and normal findings on
clinical examination; none of them was receiving medica-
tion affecting the cardiovascular system. The study was
approved by our institution ethical committee.
Echocardiographic examination
Transthoracic echocardiographic studies, including, 2-
dimensional echocardiography, pulsed Doppler, colour
Doppler, tissue Doppler imaging, and RT3D echocardio-
graphy, were performed in all patients, after placing
them in the left decubitus position. The echo study was
performed 2-3 days after blood transfusion. For this pur-
pose the Philips iE33 ultrasound machine was used
which was fully equipped with a 2D transducer and a
matrix array transducer for 3D data acquisition.
T h e2 Dd a t aw e r ea c q u i r e du s i n gt h e2 . 5M H zS 5 - 1
transducer. The dynamic range of this system was 40 Db.
Conventional measurements were obtained from para-
sternal long-axis view. Peak velocities during rapid filling,
atrial contraction (A), were measured using pulsed Dop-
pler echocardiography from the apical 4-chamber view
by positioning the sample volume at the tips of the mitral
valve, and the E/A ratio was subsequently calculated. The
early diastolic mitral annular velocity (E’) was measured
at the septal side of the mitral annulus using tissue Dop-
pler imaging in the apical 4-chamber view. The ratio E/E’
was estimated as a non-invasive LV filling pressure index.
Real-Time Three Dimensional Echocardiography and
Image analysis
Real-time 3-dimensional echocardiography imaging was
performed from the apical window using a commercial
scanner equipped with a fully sampled matrix array
transducer (x3-1), in the harmonic mode. Two full-
volume data sets were acquired from an apical window
over seven cardiac cycles, with a breath hold. The 3-
dimensional data sets were transferred to a Q-Lab sys-
tem (Philips Medical Systems, Andover, Massachusetts)
for off-line analysis. Analysis of 3-dimensional images
was based on a 2-dimensional approach, which relied on
obtaining images from an apical 4-chamber view (Addi-
tional File 1). Subsequently a semi-automated tracing of
the LA endocardial surface was generated in order to
calculate the LA volume. Tracing was performed by
marking five atrial points: the anterior, inferior, lateral,
septal mitral annuli, and the midpoint of the LA poster-
ior wall in a 4-chamber view. Once this was completed,
the endocardial border was automatically delineated,
and the LA volume was obtained throughout the heart
cycle, resulting in LA volume-time curves (Figures
1,2,3). Manual modifications were made to correct the
automatic tracings in some patients.
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cardiac cycle: (1) maximum volume (Vmax) at end-sys-
tole, just before mitral valve opening; (2) minimum
volume (Vmin) at end-diastole, just before mitral valve
closure; and (3) volume before atrial active contraction
( V p r e A )o b t a i n e df r o mt h el a s tf r a m eb e f o r em i t r a l
valve reopening or at time of the P wave on the sur-
face electrocardiogram.
Figure 1 Assessment of LA volumes using RT3DE. Automatic border detection is obtained marking 5 reference points in the apical 2- and 4-
chamber views (upper panel) and the LA 3-dimensional model is provided by the software (lower panel). The figure captures an end-systolic
frame, from which left atrial maximum volume is derived.
Figure 2 Estimation of minimum left atrial volume in the same patient using RT3DE (end-diastolic frame).
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two echocardiographers (C.A and I.F).
LA volume definitions
LA passive emptying volume (PAEV) was defined as the
maximum LA volume minus the LA volume before
atrial contraction (PAEV = Vmax-VpreA). LA active
emptying volume (AAEV) was defined as the LA volume
before atrial contraction minus the minimum LA
volume (AAEV = VpreA-Vmin). For the assessment of
the LA function the following indicators derived from
volumes were used: left atrium active emptying fraction
defined as (AAEF) = (VpreA-Vmin)/VpreAx100; and LA
passive emptying fraction (PAEF) = (Vmax-VpreA)/
Vmax100.
Statistical Analysis
Continuous variables are presented as mean ± standard
deviation of the mean or as percentage where appropri-
ate. Data were tested for normality by Kolmogorov-
Smirnov test. The means of normally distributed data
were compared using independent Student’st - t e s t .A
value of p < 0.05 was considered significant in all cases.
All tests were two-tailed. Intra- and inter-observer
agreement was assessed with the kappa statistic. Kappa
statistic values are expressed as k ± std. error. Intervals
of agreement are denoted as: kappa value greater than
0.800 denotes excellent agreement, 0.601-0.800 good
agreement, 0.401-0.600 moderate agreement, 0.400 or
less poor agreement. Data analysis was performed using
the SPSS 17.0 statistical package for Windows (SPSS
Inc, Chicago).
Results
Twenty eight patients (32 yrs old, 17 men) as well as
twenty healthy controls (31 ± 5.1 yrs old, 11 men) were
enrolled in the study. All patients with beta- thalassemia
were on chelating therapy and had no myocardial iron
according to CMR. Patient demographics are illustrated
in Table 1.
Measurements regarding conventional two-dimen-
sional echo as well Doppler indices were similar
Figure 3 Assessment of LA volume just before the atrial contraction (VpreA).
Table 1 Study population characteristics.
Variable Patients Controls P
Age (years old) 32.2 ± 4.3 31 ± 5.1 0.4
Sex (male/female) 17/11 11/9 0.7
BMI (kgr/m
2) 21.3 ± 3.8 22.1 ± 5.3 0.2
BSA (m
2) 1.2 ± 0.3 1.3 ± 0.1 0.1
Systolic BP (mmHg) 112.3 ± 12.9 114.2 ± 12.8 0.6
Diastolic BP (mmHg) 72.3 ± 7.9 75.8 ± 6.1 0.1
Heart Rate (bpm) 77.2 ± 10.3 72.1 ± 8.2 0.07
Medications
Iron chelating therapy(n of pts) 28 -
Biochemical Data
Mean Serum feritin levels (μg/l) 111 ± 84 -
Signa-MRI T2*heart (ms) 36.9 ± 5.6 -
Values are expressed as mean and standard deviation. In all case differences
were not statistically significant (p = NS).
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meter obtained by 2D-echo was 36.2 vs. 35.5 mm for
the patient and control groups respectively. It should be
noted that the participants had normal ejection fraction.
There was no statistical difference between the two
groups with regards to 2D measurements and Doppler
findings (conventional and TDI derived).
RT3DE reported no differences with regards to the
phasic changes of atrial volumes (Table 4). The mean
left atrial maximum volume assessed by 3D-echo was
35.5 vs. 31.8 ml, while the mean left atrial minimum
volume obtained by 3D-echo was 16.0 vs. 13.5 ml, for
the patient and control groups respectively. Moreover,
mean left atrial emptying volumes both passive (10.3 vs.
7.5 ml for patients and control respectively) and active
(9.3 vs. 10.8 ml for patients and controls respectively),
were not statistically different. On the contrary, the
mean atrial active emptying fraction was significantly
lower in the patient vs. the control group (34.2 vs. 48.3
ml respectively), while the mean passive emptive frac-
tion was similar for both groups (patients 27.5 vs. con-
trols 22.5 ml), as illustrated in Figure 4.
The agreement between the two readers was 0.918 ±
0.012 (0.894-0.942 95% C.I). Intra-observer agreement
was 0.892 ± 0.017 (0.859-0.925, 95% C.I).
Discussion
According to our knowledge, this is the first study that
attempts to assess phasic changes of LA volumes in
asymptomatic patients with b-thalassemia major by
employing RT3D technology. As indicated by RT3D
volumetric measurements, AAEF appears reduced in the
patient population. This reflects abnormal systolic func-
tion of the LA, even in the absence of other affected
echocardiographic parameters. This in turn could be
explained by the fact that our patients were on intense
chelating therapy, which maintained tissue iron levels
within normal range (as illustrated by serum ferritin
levels); therefore no iron accumulation was reported in
the CMR evaluation. Indeed, studies have demonstrated
that intense chelating therapy may prevent myocardial
systolic function deterioration or even improve it [8].
Moreover, it should be noted that our patients did not
have co-morbidities such as arterial hypertension or dia-
betes mellitus, which could potentially affect myocardial
systolic and diastolic performance, and thus confound
our results.
Iron toxicity is a major determinant of disease prog-
nosis in b-thalassemic patients [9]. Although MRI is the
gold standard in assessing early iron accumulation in
the myocardium, echo is more widely available and
cheaper. Monitoring ejection fraction can be useful, but
its value is limited by the masking of ventricular dys-
function via the basal high cardiac output seen in
chronic anaemia, and its late occurrence in the disease
process [10]. Even modern contractile measures, such as
tissue Doppler imaging, correlate poorly with cardiac
iron. In a TDI study conducted by Silvilairat et al.[ 1 1 ] ,
diastolic dysfunction was completely absent in patients
who had ferritin levels below 2500 ng/ml. This observa-
tion was consistent with our results. Furthermore, data
by Kremastinos [12] illustrated diastolic abnormalities
Table 2 Echocardiographic data derived by conventional
2D measurements.
Parameters Patients Controls p
LA diameter (mm) 36.2 ± 4.1 35.5 ± 3.5 0.5
Ascending Aorta (mm) 27.9 ± 2.7 29.3 ± 3.4 0.1
End-diastolic diameter of the LV (mm) 44.8 ± 3.4 46.1 ± 2.6 0.1
End-systolic diameter of the LV(mm) 29.4 ± 1.5 28,9 ± 1,2 0.4
Ejection Fraction (%) 59 ± 2.5 60.0 ± 2.1 0.1
Intraventricular septum diameter (mm) 8.2 ± 0.8 8.2 ± 0.9 0.9
LV posterior wall diameter (mm) 8.2 ± 0.8 8.2 ± 0.8 0.8
RV diameter (mm) 27.9 ± 1.9 27.4 ± 1.7 0.3
Values are expressed as mean and standard deviation. LA = left atrial; LV =
left ventricle; RV = right ventricle. In all cases differences were not statistically
significant (p = NS).
Table 3 Pulse Doppler and TDI parameters.
Variable Patients Controls p
E (cm/s) 67.7 ± 5.9 70.45 ± 8.0 0.1
A (cm/s) 45.25 ± 5.9 45.6 ± 5.7 0.8
E/A 1.5 ± 0.1 1.6 ± 0.1 0.3
E’ (cm/s) 13.9 ± 1.9 14.3 ± 2.0 0.5
E/E’ 4.9 ± 0.8 4.9 ± 0.7 0.9
IVRT (msec) 59 ± 31 61 ± 28 0.6
DT (msec) 141 ± 38 136 ± 44 0.8
Values are expressed as mean and standard deviation. IVRT = isovolumic
relaxation time; DT = deceleration time. In all cases differences were not
statistical significant (p = NS).
Table 4 Left atrial volumes (ml) as calculated by RT3D
P Patients Controls
Vmax 35.5 ± 13.4 31.8 ± 9.8
0.2
Vmin 16.0 ± 6.0 13.5 ± 4.2
0.1
VpreA 25.4 ± 9.8 24.3 ± 7.2
0.7
AAEV 9.3 ± 5.1 10.8 ± 4.7
0.3
TAEV 19.7 ± 9.7 18.2 ± 8.3
0.5
PAEV 10.3 ± 7.6 7.5 ± 3.7
0.1
Values are expressed as mean and standard deviation. AAEV = active atrial
emptying volume; TAEV = total atrial emptying volume; PAEV = passive atrial
emptying volume; TAEV = total atrial emptying volume.
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have suggested strain indices as potential markers of
early myocardial dysfunction in young asymptomatic
patients, who nevertheless had myocardial iron as sug-
gested by the reduced T2* values on MRI. Again in that
study all conventional echo measurements failed to illus-
trate any significance between the patient and the
healthy control groups.
On the other hand, left atrial volumetric assessment
employing RT3D seems to offer an alternative approach
as it can provide useful clinical information in early dis-
ease states, regardless of the left ventricular ejection
fraction [5]. In our study, the impaired AAEF reflects
early dysfunction of the left atrium, which could be
attributed to the fact that the LA is formed by thin
walls that are earlier affected as compared to the left
ventricular wall. The early impairment of left atrial func-
tion in thalassemia major has also been implicated by
studies in asymptomatic thalassemic individuals employ-
ing biochemical parameters such as atrial natriuretic
peptides [14,15]. In addition to that, Trikas et al.h a v e
illustrated that LAEF was reduced in well-preserved tha-
lassemic patients, a finding that was verified by our
results. According to the same authors, this reduction
was associated with reduced exercise capacity [16].
The echocardiographic evaluation of LA dimensions
and performance is a matter of intense research. LA
diameters as measured with 2D and M-Mode from the
parasternal view tend to underestimate the true atrial
dimensions, although they are useful and widely avail-
able [17]. Enlargement of the LA is often asymmetrical
and may occur in the medial-lateral as well as the super-
ior-inferior axes, due to limited anteroposterior axis
enlargement by the thoracic cavity. These limitations led
to the establishment of atrial volumes as more accurate
indices for the evaluation of LA dimensions [18,19].
Although LA volumes are influenced by body type, this
was not the case in our study since both groups had
similar BMI and BSA. As suggested by Cameli [20] and
other investigators [21], a relatively novel technique for
the assessment of atrial function would be the utilization
of strain rate imaging. As stated by the authors, this
could provide a useful insight into the pathophysiology
of various cardiovascular diseases, since it is a feasible
and reproducible technique. It should be noted though
that this method has major limitations, such as the
inability of capturing a region of interest resembling the
atrial shape or the confounding effects on the echo sig-
nal by structures surrounding the left atrium [20].
More recently, LA volume has been measured using
real-time 3D echocardiography that has shown good
agreement with other imaging modalities including mag-
netic resonance imaging [22,23]. Additionally, 3DE
direct volumetric and 3D speckle-tracking methods give
Figure 4 Graph illustrating atrial emptying fractions (% mean values).
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LA volumes and function; this renders interchangeable
application a viable option in daily clinical practice [24].
Left atrial volume assessment by 3D echocardiography
has the most favourable test-retest variation with the
least intra- and inter-observer variability compared with
other echocardiographic techniques, with good correla-
tions between biplane 2D and 3D measurements [25].
Moreover, RT3D can overcome limitations due to geo-
metric assumptions, which is a main drawback of the
two-dimensional approach [26]. For all these reasons,
RT3D was chosen as the method of reference for the
more accurate evaluation of LA volumes.
However, studies on 3D echo measurement of LA
volume have been limited, and there is no consensus on
the methods or comparisons with established normal
values. In addition, the low frame-rates achieved by the
X3-1 transducer constitute a major limitation. Further-
more, we did not employ strain and strain rate measure-
ments, which could provide information on early atrial
involvement in our study population [13,27]. Biochem-
ical parameters such as natriuretic peptides have not
been assessed, which could lead to correlations of clini-
cal significance.
Conclusions
Real-time 3D seems to be a novel method for the accu-
rate assessment of LA phasic changes in asymptomatic
patients with b-thalassemia major. Additionally, AAEF
may represent an early index of impaired left atrial per-
formance in the specific population. In turn, left atrial
dysfunction could be related to the increased incidence
of arrhythmias and reduced functional capacity during
exercise in thalassemic patients. Our results imply that
left atrial function should be thoroughly investigated by
clinicians.
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